ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

1 links1 made here, not in the record1 judgments1 judge (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Record updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05053334Biosimilar Study ComparingPK, PD, Safety andImmunogencity of BP11 WithUS Licensed Xolair and EUApproved XolairSyneos HealthPhase 1 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedDRUGSOmalizumabMade here · Found by reading; no entr…›Nov 4 · Claude Opus 5.5 · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Omalizumab

Made here1 judgment on this link
NCT05053334gives it, found by reading the recordOmalizumabDefined by Claude Opus 5.5Nov 4, 2026, 8:28 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 4Omalizumabmade hereClaude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change